Browse > Article
http://dx.doi.org/10.7314/APJCP.2012.13.7.3103

LY294002 Induces G0/G1 Cell Cycle Arrest and Apoptosis of Cancer Stem-like Cells from Human Osteosarcoma Via Down-regulation of PI3K Activity  

Gong, Chen (Department of Orthopedics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology)
Liao, Hui (Department of Orthopedics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology)
Wang, Jiang (Department of Orthopedics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology)
Lin, Yang (Department of Orthopedics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology)
Qi, Jun (Department of Orthopedics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology)
Qin, Liang (Department of Orthopedics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology)
Tian, Lin-Qiang (Department of Orthopedics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology)
Guo, Feng-Jing (Department of Orthopedics, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology)
Publication Information
Asian Pacific Journal of Cancer Prevention / v.13, no.7, 2012 , pp. 3103-3107 More about this Journal
Abstract
Osteosarcoma, the most common primary mesenchymal malignant tumor, usually has bad prognosis in man, with cancer stem-like cells (CSCs) considered to play a critical role in tumorigenesis and drug-resistance. It is known that phosphatidylinositol 3-kinase (PI3K) is involved in regulation of tumor cell fates, such as proliferation, cell cycling, survival and apoptosis. Whether and how PI3K and inhibitors might cooperate in human osteosarcoma CSCs is still unknown. We therefore evaluated the effects of LY294002, a PI3K inhibitor, on the cell cycle and apoptosis of osteosarcoma CSCs in vitro. LY294002 prevented phosphorylation of protein kinase B (PKB/Akt) by inhibition of PI3K phosphorylation activity, thereby inducing G0/G1 cell cycle arrest and apoptosis in osteosarcoma CSCs. Further studies also demonstrated that apoptosis induction by LY294002 is accompanied by activation of caspase-9, caspase-3 and PARP, which are involved in the mitochondrial apoptosis pathway. Therefore, our results indicate PI3K inhibitors may represent a potential strategy for managing human osteosarcoma via affecting CSCs.
Keywords
PI3K/Akt pathway; osteosarcoma; cancer stem-like cells; cell cycle; apoptosis;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Casagrande F, Bacqueville D, Pillaire MJ, et al (1998). G1 phase arrest by the phosphatidylinositol 3-kinase inhibitor LY 294002 is correlated to up-regulation of p27Kip1 and inhibition of G1 CDKs in choroidal melanoma cells. FEBS Lett, 422, 385-90.   DOI
2 Coffey JC, Wang JH, Smith MJ, et al (2005). Phosphoinositide 3-kinase accelerates postoperative tumor growth by inhibiting apoptosis and enhancing resistance to chemotherapy-induced apoptosis. Novel role for an old enemy. J Biol Chem, 280, 20968-77.   DOI
3 Dick JE (2008). Stem cell concepts renew cancer research. Blood, 112, 4793-807.   DOI
4 Eyler CE, Foo WC, LaFiura KM, et al (2008). Brain cancer stem cells display preferential sensitivity to Akt inhibition. Stem Cells, 26, 3027-36.   DOI   ScienceOn
5 Frank NY, Schatton T, Frank MH (2010). The therapeutic promise of the cancer stem cell concept. J Clin Invest, 120, 41-50.   DOI
6 Gibbs CP, Kukekov VG, Reith JD, et al (2005). Stem-like cells in bone sarcomas: implications for tumorigenesis. Neoplasia, 7, 967-76.   DOI
7 Hanahan D, Weinberg RA (2000). The hallmarks of cancer. Cell, 100, 57-70.   DOI   ScienceOn
8 Jiang H, Fan D, Zhou G, Li X, Deng H (2010). Phosphatidylinositol 3-kinase inhibitor (LY294002) induces apoptosis of human nasopharyngeal carcinoma in vitro and in vivo. J Exp Clin Cancer Res, 29, 34.   DOI
9 Lee CM, Fuhrman CB, Planelles V, et al (2006). Phosphatidylinositol 3-kinase inhibition by LY294002 radiosensitizes human cervical cancer cell lines. Clin Cancer Res, 12, 250-6.   DOI
10 Liu B, Ma W, Jha RK, Gurung K (2011). Cancer stem cells in osteosarcoma: recent progress and perspective. Acta Oncol, 50, 1142-50.   DOI
11 Luan Y, Yang Q, Xie Y, et al (2011). A sensitive near-infrared fluorescent probe for caspase-mediated apoptosis: Synthesis and application in cell imaging. Drug Discov Ther, 5, 220-6.
12 Meyers PA, Schwartz CL, Krailo M, et al (2005). Osteosarcoma: a randomized, prospective trial of the addition of ifosfamide and/or muramyl tripeptide to cisplatin, doxorubicin, and high-dose methotrexate. J Clin Oncol, 23, 2004-11.   DOI
13 Rosen JM, Jordan CT (2009). The increasing complexity of the cancer stem cell paradigm. Science, 324, 1670-3.   DOI
14 Semba S, Itoh N, Ito M, Harada M, Yamakawa M (2002). The in vitro and in vivo effects of 2-(4-morpholinyl)-8-phenyl-chromone (LY294002), a specific inhibitor of phosphatidylinositol 3'-kinase, in human colon cancer cells. Clin Cancer Res, 8, 1957-63.
15 Visvader JE, Lindeman GJ (2008). Cancer stem cells in solid tumours: accumulating evidence and unresolved questions. Nat Rev Cancer, 8, 755-68.   DOI   ScienceOn
16 Teranishi F, Takahashi N, Gao N, et al (2009). Phosphoinositide 3-kinase inhibitor (wortmannin) inhibits pancreatic cancer cell motility and migration induced by hyaluronan in vitro and peritoneal metastasis in vivo. Cancer Sci, 100, 770-7.   DOI
17 Tirino V, Desiderio V, D'Aquino R, et al (2008). Detection and characterization of CD133+ cancer stem cells in human solid tumours. PLoS One, 3, e3469.   DOI
18 Veselska R, Hermanova M, Loja T, et al (2008). Nestin expression in osteosarcomas and derivation of nestin/CD133 positive osteosarcoma cell lines. BMC Cancer, 8, 300.   DOI
19 Walker EH, Pacold ME, Perisic O, et al (2000). Structural determinants of phosphoinositide 3-kinase inhibition by wortmannin, LY294002, quercetin, myricetin, and staurosporine. Mol Cell, 6, 909-19.   DOI   ScienceOn
20 Wilson H, Huelsmeyer M, Chun R, et al (2008). Isolation and characterisation of cancer stem cells from canine osteosarcoma. Vet J, 175, 69-75.   DOI
21 Xu Q, Simpson SE, Scialla TJ, Bagg A, Carroll M (2003). Survival of acute myeloid leukemia cells requires PI3 kinase activation. Blood, 102, 972-80.   DOI
22 Zhang F, Chen A, Chen J, Yu T, Guo F (2011). SiRNA-mediated silencing of beta-catenin suppresses invasion and chemosensitivity to doxorubicin in MG-63 osteosarcoma cells. Asian Pac J Cancer Prev, 12, 239-45.
23 Zhang Y, Johansson E, Miller ML, et al (2011). Identification of a conserved anti-apoptotic protein that modulates the mitochondrial apoptosis pathway. PLoS One, 6, e25284.   DOI
24 Zhao C, Chen A, Jamieson CH, et al (2009). Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia. Nature, 458, 776-9.   DOI